Key facts
- Notable investors include Firstgate (South Korea).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SonoPharma
- ·The full record, as it builds
Funding rounds
No funding rounds for SonoPharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SonoPharma
Manufacturer of noninvasive medical devices designed to improve kidney function. The company develops fixed hospital equipment and wearable home devices using Low-Intensity Focused Ultrasound technology, enabling patients and healthcare providers to manage kidney disease and monitor treatment with reduced reliance on pharmacological agents.
- Sector
- Healthcare
- HQ
- Jeonju, South Korea
- Founded
- 2025
- Website
- sonopharma.co.kr/
- Ownership
- Privately Held (backing)
SonoPharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SonoPharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SonoPharma in its N-PORT filings yet. We sweep new filings monthly.